Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2025 09:00 ET | Source: JAKKS Pacific Inc.

Disguise Secures New Rights to the Core IP for Sonic the Hedgehog™ in Multi-Year Deal with SEGA of America

Disguise Secures New Rights to the Core IP for Sonic the Hedgehog™ in Multi-Year Deal with SEGA of America
April 15, 2025 08:00 ET | Source: Lisata Therapeutics, Inc.

Lisata Therapeutics Announces Research License with Catalent

BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
April 15, 2025 03:00 ET | Source: Cyprumed GmbH

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $493 million in upfront, development, regulatory...
April 14, 2025 08:01 ET | Source: Liberty Defense

Liberty Defense Garners Another Sale of the HEXWAVE Unit & Another New Channel Sales Partner for the Country of Brazil & Launching of a Significant Capital Markets Investor Awareness Campaign

WILMINGTON, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: FSE:E30), a leading technology provider of...
April 10, 2025 09:00 ET | Source: G-III Apparel Group, LTD.

G-III Apparel Group and the ALDO Group Announce Licensing Agreement for G.H.BASS Footwear, Bags and Small Leather Goods

NEW YORK and MONTREAL, April 10, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (Nasdaq: GIII) and ALDO Product Services (APS), a division of the ALDO Group, today announced a new strategic...
April 09, 2025 08:00 ET | Source: Glass House Brands Inc.

Glass House Brands Announces Hemp Research and Development Agreement with the University of California, Berkeley

LONG BEACH, Calif. and TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...
April 09, 2025 06:00 ET | Source: Global Net Lease, Inc.

Lease Agreement Between Global Net Lease and General Services Administration (GSA) Remains in Full Effect

Lease Agreement Between Global Net Lease and General Services Administration (GSA) Remains in Full Effect
April 08, 2025 08:45 ET | Source: Outlook Therapeutics, Inc.

Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that...
April 08, 2025 08:31 ET | Source: Sixty Degrees Pharmaceuticals

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

60 Degrees Pharma partners with Yale to develop tafenoquine for treating and preventing babesiosis, a severe tick-borne disease with limited treatments.
April 02, 2025 05:28 ET | Source: KuicK Research

VISTA Inhibitor Clinical Trials Market Size FDA Approval Patent Report 2025

Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global VISTA Inhibitor Clinical Trials, Drug Development Opportunities & Patent Insight 2025 Report Highlights & Findings: First VISTA...